Heidi Klepin is an Oncology physician affiliated with Wake Forest University. OpenAlex indexes 342 publications with 12,136 citations (h-index 50); ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Medical Center Blvd
Winston-Salem, NC 27157
Telephone
336-716-2255Registry record last updated 12 May 2008.
Clinical trials
- Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
Sponsor: Wake Forest University Health Sciences
- Aging and Frailty Study
Sponsor: Wake Forest University Health Sciences
- Muscadine Grape Extract to Improve Fatigue
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20221 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Aromatase Inhibitor100%Anastrozole100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Minimizing Physical Function Decline in Older Adults Receiving Chemotherapy
Wake Forest University Health Sciences
FY2014$140,878K23AG038361
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Older adult participation in cancer clinical trials: A systematic review of barriers and interventions
CA A Cancer Journal for Clinicians
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Yeboah, MD
Wake Forest University
Bayard Powell, MD
Wake Forest University
Joseph Jorizzo, MD
Wake Forest University
Edward Haponik, MD
Wake Forest University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”